AlphaMeld
Agent layer

Network design, orchestrated agents, latest models.

Built for drug-discovery rigor. Knowledge Graph extraction → LLM verification → agentic deep-dive → ranked outputs with evidence — at scale, reproducibly.

01

Network Design

Enhanced knowledge-graph network design — dense, typed, and queryable for multi-hop biology.

02

Agent Orchestration

Purpose-built workflows chain reasoning, retrieval, tool use, and verification.

03

Curated Agents

Scientifically curated agents encode deep domain knowledge across modalities and therapeutic areas.

04

Latest Models

Frontier LLMs routed per task — efficient, auditable, and cost-controlled.

Capabilities

Eight curated agents. One orchestration layer. Each runs as a FastAPI workflow with a deterministic interface.

C.01

Knowledge graph reasoning

Multi-hop traversal across targets, diseases, drugs, endpoints, and pathways.

C.02

Target identification

Genetic, druggability, IP, and safety priors triangulated into ranked candidate lists.

C.03

Indication discovery

From a single target, surface and prioritize additional indications.

C.04

Hypothesis validation

Stress-test hypotheses against KG and literature; produce a diligence dossier.

C.05

Trial design

Endpoint selection, phase-transition prediction, and competitor-aware positioning.

C.06

TPP audit

Compare defined Target Product Profiles against actual readouts; surface drift.

C.07

Safety assessment

On- and off-target liabilities, population signals, and competitor safety benchmarks.

C.08

Reports synthesis

Templated, diligence-grade reports with full provenance and source linking.

Get started

Ready to compress your discovery timelines?

See AlphaMeld run a live target-discovery workflow on your therapy area in 30 minutes.